aser En Bloc Resection in Bladder Cancer: Holmium vs. Thulium Trial
Not Applicable
- Conditions
- Health Condition 1: C67- Malignant neoplasm of bladder
- Registration Number
- CTRI/2024/04/065452
- Lead Sponsor
- Post Graduate Institute of Medical Education & Research, Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with Urinary Bladder mass presenting for the first time with single tumor on imaging and the tumor size less than 4 cm.
Exclusion Criteria
1)Patients who have received any form of intravesical/systemic chemotherapy elsewhere.
2)Patients with obvious extravesical disease on CECT (radiologically more than or equal to T3)
3)Tumor size more than 4 cm.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of ThuLERBT in comparison with HoLERBT in tumor histopathological staging and detrusor muscle sampling for biopsy.Timepoint: operation time ,Number of growths,Morphology, <br/ ><br>Mean diameter of tumor (cm), <br/ ><br>Tumor location, Completion of resection <br/ ><br>Obturator jerk <br/ ><br>Bladder perforation (if any) <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Incidence of residual tumour and tumour upstaging in restage HoLERBT / ThuLERBTTimepoint: During the postoperative period, specifically when the restaging procedures are performed;Periprocedural complications between ThuLERBT and HoLERBT in terms of bleeding and obturator nerve jerk.Timepoint: real-time as the interventions are being carried out